Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Lymphoid 1Genitourinary 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 16Breast Neoplasms 13Lung Neoplasms 9Carcinoma, Renal Cell 7Rectal Neoplasms 5Pancreatic Neoplasms 5Neoplasms 5Lymphoma 5Colorectal Neoplasms 5Colonic Neoplasms 5Uterine Cervical Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Glioblastoma 4Esophageal Neoplasms 4Breast Neoplasms, Male 4Sarcoma 3Melanoma 3Lymphoma, Large B-Cell, Diffuse 3Kidney Neoplasms 3Hodgkin Disease 3Head and Neck Neoplasms 3Esophageal Squamous Cell Carcinoma 3Brain Neoplasms 3Adenocarcinoma Of Esophagus 3Urinary Bladder Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 2Thyroid Neoplasms 2Thyroid Cancer, Papillary 2Stomach Neoplasms 2Spinal Cord Neoplasms 2

Interventions

Rituximab 47Cyclophosphamide 26fludarabine 13ibrutinib 12Doxorubicin 11Vincristine 10Etoposide 10Cytarabine 10Prednisone 9Bortezomib 9pembrolizumab 7fludarabine phosphate 6Lenalidomide 6Inotuzumab Ozogamicin 6obinutuzumab 5Mycophenolic Acid 5Melphalan 5Carmustine 5tositumomab I-131 4ibritumomab tiuxetan 4Tacrolimus 4Prednisolone 4Methotrexate 4Gemcitabine 4Bendamustine Hydrochloride 4Antilymphocyte Serum 4tocilizumab 3tazemetostat 3Whole-Body Irradiation 3Vorinostat 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lymphoma, B-Cell × Fluorodeoxyglucose F18 × Clear all
NCT02599194 2019-01-03

18F-FSPG PET/CT for Cancer Patients on Therapy

Stanford University

Phase 2 Completed
7 enrolled 6 charts
BreastGenitourinaryLymphoidOther solid neoplasmThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Mesothelioma, Lymphoma, B-Cell, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡